Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Weiss

Showing results (31-40 of 99) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1986
Use of in vitro dose response effects to select antineoplastics for high-dose or regional administration regimensD D Von Hoff, G M Clark, G R Weiss, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
A phase I trial of combination therapy with continuous-infusion PALA and continuous-infusion 5-FUG R Weiss, T J Ervin, M W Meshad, et al.
The Cancer Journal From Scientific American|June 5, 1998
The treatment of metastatic renal cell carcinoma patients with recombinant human gamma interferonE J Small, G R Weiss, U K Malik, et al.
Chest|December 1, 1991
Intrapleural therapy for malignant pleural effusions. A randomized comparison of bleomycin and tetracyclineJ C Ruckdeschel, D Moores, J Y Lee, et al.
Investigational New Drugs|January 1, 1996
Pharmacokinetic profile of Mitoguazone (MGBG) in patients with AIDS related non-Hodgkin's lymphomaJ Rizzo, A M Levine, G R Weiss, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1993
New anticancer agentsG R Weiss, H A Burris, J R Eckardt, et al.
Anti-Cancer Drugs|June 1, 1996
A randomized phase I study of oral etoposide with or without granulocyte-macrophage colony-stimulating factor for the treatment of patients with advanced cancerG R Weiss, D W Shaffer, C DeMoor, et al.
Cancer Treatment Reports|September 1, 1986
Phase II study of fludarabine phosphate for the treatment of advanced non-small cell carcinoma of the lung: a Southwest Oncology Group StudyG R Weiss, J Crowley, D D Von Hoff, et al.
American Journal of Clinical Oncology|October 1, 1995
Phase II trial of CHIP for the treatment of advanced, hormonally refractory carcinoma of the prostate. A Southwest Oncology Group StudyM E Marshall, M K Wolf, E D Crawford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Phase I clinical investigation of amonafideR Saez, J B Craig, J G Kuhn, et al.
Pageof 10

Showing results (31-40 of 99) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1986
Use of in vitro dose response effects to select antineoplastics for high-dose or regional administration regimensD D Von Hoff, G M Clark, G R Weiss, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
A phase I trial of combination therapy with continuous-infusion PALA and continuous-infusion 5-FUG R Weiss, T J Ervin, M W Meshad, et al.
The Cancer Journal From Scientific American|June 5, 1998
The treatment of metastatic renal cell carcinoma patients with recombinant human gamma interferonE J Small, G R Weiss, U K Malik, et al.
Chest|December 1, 1991
Intrapleural therapy for malignant pleural effusions. A randomized comparison of bleomycin and tetracyclineJ C Ruckdeschel, D Moores, J Y Lee, et al.
Investigational New Drugs|January 1, 1996
Pharmacokinetic profile of Mitoguazone (MGBG) in patients with AIDS related non-Hodgkin's lymphomaJ Rizzo, A M Levine, G R Weiss, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1993
New anticancer agentsG R Weiss, H A Burris, J R Eckardt, et al.
Anti-Cancer Drugs|June 1, 1996
A randomized phase I study of oral etoposide with or without granulocyte-macrophage colony-stimulating factor for the treatment of patients with advanced cancerG R Weiss, D W Shaffer, C DeMoor, et al.
Cancer Treatment Reports|September 1, 1986
Phase II study of fludarabine phosphate for the treatment of advanced non-small cell carcinoma of the lung: a Southwest Oncology Group StudyG R Weiss, J Crowley, D D Von Hoff, et al.
American Journal of Clinical Oncology|October 1, 1995
Phase II trial of CHIP for the treatment of advanced, hormonally refractory carcinoma of the prostate. A Southwest Oncology Group StudyM E Marshall, M K Wolf, E D Crawford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Phase I clinical investigation of amonafideR Saez, J B Craig, J G Kuhn, et al.
Pageof 10